U.S. Stock Futures Rise as Trump Launches Drug Price Website
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 2d ago
0mins
Should l Buy AFRM?
Source: Benzinga
- Futures Rise: U.S. stock futures advanced on Friday after Thursday's sharp sell-off, indicating a potential recovery in investor sentiment and possibly leading to increased capital inflows into the market.
- Trump's Drug Price Website: President Trump announced the launch of a new website aimed at lowering drug prices, which will provide consumers access to more affordable prescription medications, potentially impacting pricing strategies in the pharmaceutical industry and raising public awareness about drug accessibility.
- Jobs Report Delayed: The January jobs report, originally scheduled for release today, has been postponed to next Wednesday due to the partial government shutdown earlier this week, which may affect short-term market expectations regarding economic health and increase investor uncertainty.
- Stable Treasury Yields: The 10-year Treasury bond yield stood at 4.20%, while the two-year bond yield was at 3.48%, reflecting market expectations of unchanged interest rates; the CME Group's FedWatch tool indicates an 81.3% likelihood of this, which could influence investors' asset allocation strategies.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy AFRM?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on AFRM
Wall Street analysts forecast AFRM stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for AFRM is 95.50 USD with a low forecast of 83.00 USD and a high forecast of 114.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
18 Analyst Rating
12 Buy
6 Hold
0 Sell
Moderate Buy
Current: 59.420
Low
83.00
Averages
95.50
High
114.00
Current: 59.420
Low
83.00
Averages
95.50
High
114.00
About AFRM
Affirm Holdings, Inc. provides consumers with an alternative to traditional payment options. The Company is engaged in building a payment network. Its platform comprises three core elements: point-of-sale payment solutions for consumers, merchant commerce solutions, and a consumer-focused app. Its Affirm App and Website provide tailored offers from merchants based on consumers' preferences. Consumers can apply at affirm.com or via the Affirm App and, upon approval, receive a single-use virtual card to use online or in-store. Its Affirm Card allows consumers to link a bank account to pay in full, or apply to pay overtime through the Affirm App. It offers users an in-app post-purchase feature that allows them to instantly apply to convert any eligible debit transaction into an installment loan. Through the Affirm app and in partnership with Cross River Bank, it offers a savings account, with no minimum deposit requirements or fees.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Affirm Reports 30% Revenue Growth in Q2
- Significant Revenue Growth: Affirm's revenue surged 30% year-over-year to $1.12 billion in Q2, exceeding the consensus estimate of $1.06 billion, indicating strong demand for its buy-now-pay-later services.
- Increased Credit Loss Provisions: The company reported a jump in credit loss provisions to $214.2 million in Q2, up from nearly $153 million a year ago, reflecting potential challenges from rising credit risks despite solid overall revenue performance.
- Interest Income Boost: Affirm's interest income grew by 21%, primarily driven by a 22% increase in average net loans held for investment, which supports the company's profitability even amid credit loss pressures.
- Optimistic Future Outlook: Affirm expects Q3 revenue to range between $970 million and $1 billion, with analysts averaging $975.7 million, showcasing confidence in future performance despite a 4% drop in stock price during after-hours trading.
See More
Affirm Reports Strong Q2 but Signals Slowing Growth Ahead
- Strong Performance: Affirm Holdings reported fiscal Q2 revenues and volumes exceeding expectations, prompting management to raise its fiscal 2026 guidance, indicating resilience in the market.
- Growth Outlook Adjustment: While the company anticipates 32%-33% volume growth for fiscal 2026, surpassing the consensus estimate of 29%, analysts expressed disappointment over the fourth quarter's GMV performance, suggesting risks of slowing growth.
- Analyst Rating Changes: JPMorgan analyst Reginald Smith maintained an Overweight rating on Affirm but reduced the price target from $94 to $79, reflecting a cautious outlook on future growth.
- Market Reaction: Affirm's shares fell 1.26% to $59.42 in premarket trading on Friday, indicating investor concerns regarding the company's slowing growth trajectory.
See More
Affirm Reports Strong Q2 Earnings, Raises Guidance
- Earnings Beat: Affirm reported earnings per share of 37 cents for Q2, surpassing the consensus estimate of 30 cents, indicating improved profitability that may attract more investor interest.
- Significant Revenue Growth: The company posted revenue of $1.12 billion, exceeding the expected $1.05 billion, demonstrating strong business expansion and market demand, which is likely to drive stock price appreciation.
- Customer and Merchant Growth: Active customers increased by 23% to 25.8 million, while active merchants rose by 42% to 478,000, showcasing Affirm's competitive edge and appeal in the market, potentially laying the groundwork for future revenue growth.
- Guidance Upgrade: Affirm raised its fiscal year 2026 revenue guidance to between $4.08 billion and $4.14 billion, reflecting confidence in future performance, which may enhance market sentiment towards its stock.
See More
Affirm Shares Decline Post-Earnings, Analysts Consider It Unjustified.
- Stock Performance: Affirm Holdings' stock declined on Friday despite reporting strong fiscal second-quarter earnings.
- Analyst Opinions: Some analysts believe the market reaction to the earnings report is unjustified.
See More
Affirm Partners with Virgin Media O2 for Flexible Financing Solutions
- Earnings Beat: Affirm reported Q2 2026 earnings of $0.37 per share, surpassing the consensus estimate of $0.30, indicating improved profitability that may boost investor confidence.
- Revenue Growth: The company achieved quarterly revenue of $1.12 billion, exceeding Wall Street's expectation of $1.06 billion, reflecting strong market demand that supports future business expansion.
- Strategic Partnership: Affirm's collaboration with Virgin Media O2 introduces transparent and flexible hardware financing options for O2 customers, enhancing O2's competitiveness in the SIM-free market, which is expected to attract more customers and increase sales.
- Positive Outlook: Affirm anticipates Q3 revenue between $970 million and $1 billion, and Q4 between $1.060 billion and $1.090 billion, while raising its FY26 revenue guidance to $4.09 billion to $4.15 billion, demonstrating confidence in future growth.
See More
U.S. Stock Futures Rise as Trump Launches Drug Price Website
- Futures Rise: U.S. stock futures advanced on Friday after Thursday's sharp sell-off, indicating a potential recovery in investor sentiment and possibly leading to increased capital inflows into the market.
- Trump's Drug Price Website: President Trump announced the launch of a new website aimed at lowering drug prices, which will provide consumers access to more affordable prescription medications, potentially impacting pricing strategies in the pharmaceutical industry and raising public awareness about drug accessibility.
- Jobs Report Delayed: The January jobs report, originally scheduled for release today, has been postponed to next Wednesday due to the partial government shutdown earlier this week, which may affect short-term market expectations regarding economic health and increase investor uncertainty.
- Stable Treasury Yields: The 10-year Treasury bond yield stood at 4.20%, while the two-year bond yield was at 3.48%, reflecting market expectations of unchanged interest rates; the CME Group's FedWatch tool indicates an 81.3% likelihood of this, which could influence investors' asset allocation strategies.
See More
Affirm Reports 30% Revenue Growth in Q2
- Significant Revenue Growth: Affirm's revenue surged 30% year-over-year to $1.12 billion in Q2, exceeding the consensus estimate of $1.06 billion, indicating strong demand for its buy-now-pay-later services.
- Increased Credit Loss Provisions: The company reported a jump in credit loss provisions to $214.2 million in Q2, up from nearly $153 million a year ago, reflecting potential challenges from rising credit risks despite solid overall revenue performance.
- Interest Income Boost: Affirm's interest income grew by 21%, primarily driven by a 22% increase in average net loans held for investment, which supports the company's profitability even amid credit loss pressures.
- Optimistic Future Outlook: Affirm expects Q3 revenue to range between $970 million and $1 billion, with analysts averaging $975.7 million, showcasing confidence in future performance despite a 4% drop in stock price during after-hours trading.
See More
Affirm Reports Strong Q2 but Signals Slowing Growth Ahead
- Strong Performance: Affirm Holdings reported fiscal Q2 revenues and volumes exceeding expectations, prompting management to raise its fiscal 2026 guidance, indicating resilience in the market.
- Growth Outlook Adjustment: While the company anticipates 32%-33% volume growth for fiscal 2026, surpassing the consensus estimate of 29%, analysts expressed disappointment over the fourth quarter's GMV performance, suggesting risks of slowing growth.
- Analyst Rating Changes: JPMorgan analyst Reginald Smith maintained an Overweight rating on Affirm but reduced the price target from $94 to $79, reflecting a cautious outlook on future growth.
- Market Reaction: Affirm's shares fell 1.26% to $59.42 in premarket trading on Friday, indicating investor concerns regarding the company's slowing growth trajectory.
See More
Affirm Reports Strong Q2 Earnings, Raises Guidance
- Earnings Beat: Affirm reported earnings per share of 37 cents for Q2, surpassing the consensus estimate of 30 cents, indicating improved profitability that may attract more investor interest.
- Significant Revenue Growth: The company posted revenue of $1.12 billion, exceeding the expected $1.05 billion, demonstrating strong business expansion and market demand, which is likely to drive stock price appreciation.
- Customer and Merchant Growth: Active customers increased by 23% to 25.8 million, while active merchants rose by 42% to 478,000, showcasing Affirm's competitive edge and appeal in the market, potentially laying the groundwork for future revenue growth.
- Guidance Upgrade: Affirm raised its fiscal year 2026 revenue guidance to between $4.08 billion and $4.14 billion, reflecting confidence in future performance, which may enhance market sentiment towards its stock.
See More
Affirm Shares Decline Post-Earnings, Analysts Consider It Unjustified.
- Stock Performance: Affirm Holdings' stock declined on Friday despite reporting strong fiscal second-quarter earnings.
- Analyst Opinions: Some analysts believe the market reaction to the earnings report is unjustified.
See More
Affirm Partners with Virgin Media O2 for Flexible Financing Solutions
- Earnings Beat: Affirm reported Q2 2026 earnings of $0.37 per share, surpassing the consensus estimate of $0.30, indicating improved profitability that may boost investor confidence.
- Revenue Growth: The company achieved quarterly revenue of $1.12 billion, exceeding Wall Street's expectation of $1.06 billion, reflecting strong market demand that supports future business expansion.
- Strategic Partnership: Affirm's collaboration with Virgin Media O2 introduces transparent and flexible hardware financing options for O2 customers, enhancing O2's competitiveness in the SIM-free market, which is expected to attract more customers and increase sales.
- Positive Outlook: Affirm anticipates Q3 revenue between $970 million and $1 billion, and Q4 between $1.060 billion and $1.090 billion, while raising its FY26 revenue guidance to $4.09 billion to $4.15 billion, demonstrating confidence in future growth.
See More
U.S. Stock Futures Rise as Trump Launches Drug Price Website
- Futures Rise: U.S. stock futures advanced on Friday after Thursday's sharp sell-off, indicating a potential recovery in investor sentiment and possibly leading to increased capital inflows into the market.
- Trump's Drug Price Website: President Trump announced the launch of a new website aimed at lowering drug prices, which will provide consumers access to more affordable prescription medications, potentially impacting pricing strategies in the pharmaceutical industry and raising public awareness about drug accessibility.
- Jobs Report Delayed: The January jobs report, originally scheduled for release today, has been postponed to next Wednesday due to the partial government shutdown earlier this week, which may affect short-term market expectations regarding economic health and increase investor uncertainty.
- Stable Treasury Yields: The 10-year Treasury bond yield stood at 4.20%, while the two-year bond yield was at 3.48%, reflecting market expectations of unchanged interest rates; the CME Group's FedWatch tool indicates an 81.3% likelihood of this, which could influence investors' asset allocation strategies.
See More
